Imprinted gene expression in early life determines body composition and response to the obesogenic environment.

生命早期的印记基因表达决定了身体成分和对肥胖环境的反应。

基本信息

  • 批准号:
    MR/S00002X/1
  • 负责人:
  • 金额:
    $ 100.3万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

Obesity and related disorders, including type 2 diabetes and cardiovascular disease, are major health problems in the UK and many other parts of the world. Over 20% of UK adults were classed as obese in 2004 and this will reach over 50% by 2050 unless current trends can be halted. Obesity-related problems were estimated to cost the NHS around £1bn in 2007 and this is predicted to rise to almost £10bn by 2050. The true financial and societal costs are much greater. These metabolic health problems are generally attributed to the combined effects of poor diet and insufficient exercise. However, it has also become clear that poor metabolic health can be reinforced from one generation to the next. This is partly due to inherited factors and partly due to the environment experienced during early life. Throughout the critical growth periods in the womb and as suckling infants, babies experience an environment that is heavily influenced by the health status and habits of their mother. A mother's diet (as well as factors such as smoking and alcohol consumption), maternal obesity and gestational diabetes can have life-long effects on the health of her offspring. However, how these genetic and environmental factors influence growth during early life is poorly understood. In addition to body size we need to consider changes in the proportions of lean (mainly muscle) and fat tissues that are laid down during early life development.We have been studying a group of genes that have a strong influence on early life growth and may be unusually sensitive to environmental factors such as maternal diet. Two of these genes, Dlk1 and Grb10, influence body size and lean:fat proportions in opposite directions. Dlk1 promotes growth, including size at birth, and also the accumulation of fat tissue in later life. Conversely, Grb10 restricts growth in early life and limits the accumulation of fat later on. Using mouse genetics, we aim to test the idea that these genes act in early life to establish lean:adipose proportions. We will establish how Dlk1 and Grb10 act at the level of cells and molecules. One set of experiments will allow us to determine their actions in developing fat tissue. Another set of experiments will focus on their roles in muscle development. We will test the effects of each gene on fat deposition in adult life when mice are challenged with a high fat diet. Together, these experiments will tell us how these genes could affect life-long health by influencing normal growth processes during early life. In addition, we will test our idea that the two genes act antagonistically, pushing and pulling body size and proportions in opposite directions. This will allow us to identify other key genes involved in these important processes.
肥胖和相关疾病,包括2型糖尿病和心血管疾病,是英国和世界许多其他地区的主要健康问题。2004年,超过20%的英国成年人被归类为肥胖,到2050年,这一比例将超过50%,除非目前的趋势可以停止。据估计,2007年,与肥胖有关的问题花费了NHS约10亿英镑,预计到2050年将增加到近100亿英镑。真正的经济和社会成本要大得多。这些代谢健康问题通常归因于不良饮食和运动不足的综合影响。然而,人们也清楚地看到,不良的代谢健康可以从一代人到下一代人得到加强。这部分是由于遗传因素,部分是由于早年经历的环境。在子宫内和哺乳期的整个关键生长期,婴儿所经历的环境受到母亲健康状况和习惯的严重影响。母亲的饮食(以及吸烟和饮酒等因素)、母亲肥胖和妊娠期糖尿病可能对其后代的健康产生终身影响。然而,这些遗传和环境因素如何影响生命早期的生长却知之甚少。除了体型,我们还需要考虑在生命早期发育过程中形成的瘦肉(主要是肌肉)和脂肪组织比例的变化。我们一直在研究一组对生命早期发育有很大影响的基因,这些基因可能对环境因素(如母亲的饮食)异常敏感。其中两个基因,Dlk1和Grb10,以相反的方向影响身体大小和瘦:脂肪比例。Dlk1促进生长,包括出生时的大小,以及以后生活中脂肪组织的积累。相反,Grb10限制了生命早期的生长,并限制了以后脂肪的积累。使用小鼠遗传学,我们的目标是测试这些基因在生命早期建立瘦肉:脂肪比例的想法。我们将确定Dlk 1和Grb 10如何在细胞和分子水平上起作用。一组实验将使我们能够确定它们在脂肪组织发育中的作用。另一组实验将集中在它们在肌肉发育中的作用。我们将测试每个基因对成年后脂肪沉积的影响,当小鼠受到高脂肪饮食的挑战时。总之,这些实验将告诉我们这些基因如何通过影响生命早期的正常生长过程来影响终身健康。此外,我们将测试我们的想法,这两个基因的行为是对立的,推动和拉动身体的大小和比例在相反的方向。这将使我们能够确定参与这些重要过程的其他关键基因。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dlk1 dosage regulates hippocampal neurogenesis and cognition.
Dynamic Expression of Imprinted Genes in the Developing and Postnatal Pituitary Gland.
  • DOI:
    10.3390/genes12040509
  • 发表时间:
    2021-03-30
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Scagliotti V;Costa Fernandes Esse R;Willis TL;Howard M;Carrus I;Lodge E;Andoniadou CL;Charalambous M
  • 通讯作者:
    Charalambous M
A pipeline for making 31 P NMR accessible for small- and large-scale lipidomics studies
使 31 P NMR 可用于小规模和大规模脂质组学研究的管道
  • DOI:
    10.17863/cam.73457
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Furse S
  • 通讯作者:
    Furse S
Imprinted Gene Expression and Function of the Dopa Decarboxylase Gene in the Developing Heart.
  • DOI:
    10.3389/fcell.2021.676543
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Prickett AR;Montibus B;Barkas N;Amante SM;Franco MM;Cowley M;Puszyk W;Shannon MF;Irving MD;Madon-Simon M;Ward A;Schulz R;Baldwin HS;Oakey RJ
  • 通讯作者:
    Oakey RJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marika Charalambous其他文献

Mapping regulatory elements at the DLK1 locus involved in the pathogenesis of human fetal growth restriction
  • DOI:
    10.1016/j.placenta.2023.07.240
  • 发表时间:
    2023-09-07
  • 期刊:
  • 影响因子:
  • 作者:
    Maria Lillina Vignola;Bertille Montibus;Valeria Scagliotti;Rebecca Oakey;Alan Hodgkinson;Marika Charalambous
  • 通讯作者:
    Marika Charalambous
Single-cell RNA sequencing of the maternal hypothalamus reveals a distinct neuroendocrine transcriptome in pregnancy.
  • DOI:
    10.1016/j.placenta.2023.07.134
  • 发表时间:
    2023-09-07
  • 期刊:
  • 影响因子:
  • 作者:
    Risha Amarsi;Benjamin Jones;Pawan Dhami;Thea Willis;Marika Charalambous
  • 通讯作者:
    Marika Charalambous
Placental expression of Delta-like homologue 1 (Dlk1) regulates endothelial cell development and hormone production to modulate fetal growth and maternal fatty acid metabolism
  • DOI:
    10.1016/j.placenta.2023.07.204
  • 发表时间:
    2023-09-07
  • 期刊:
  • 影响因子:
  • 作者:
    Valeria Scagliotti;Maria Vignola;Ruben Esse;Marika Charalambous
  • 通讯作者:
    Marika Charalambous

Marika Charalambous的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marika Charalambous', 18)}}的其他基金

Lipid Metabolism in Pregnancy: Adipose-Placental Interactions
妊娠期脂质代谢:脂肪-胎盘相互作用
  • 批准号:
    BB/X007758/1
  • 财政年份:
    2023
  • 资助金额:
    $ 100.3万
  • 项目类别:
    Research Grant
Investigating a novel molecular diagnostic tool for identification and stratification of pregnancy complications
研究一种用于妊娠并发症识别和分层的新型分子诊断工具
  • 批准号:
    MR/R022836/1
  • 财政年份:
    2018
  • 资助金额:
    $ 100.3万
  • 项目类别:
    Research Grant
Communication between mother and fetus : Imprinting and endocrine adaptations to pregnancy
母亲和胎儿之间的交流:妊娠印记和内分泌适应
  • 批准号:
    MR/L002345/2
  • 财政年份:
    2017
  • 资助金额:
    $ 100.3万
  • 项目类别:
    Research Grant
Communication between mother and fetus : Imprinting and endocrine adaptations to pregnancy
母亲和胎儿之间的交流:妊娠印记和内分泌适应
  • 批准号:
    MR/L002345/1
  • 财政年份:
    2014
  • 资助金额:
    $ 100.3万
  • 项目类别:
    Research Grant

相似国自然基金

基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
  • 批准号:
    32372856
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
  • 批准号:
    32000546
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
p53/SNHG1/TAF1调控环路通过PKM2调控细胞糖酵解机制的研究
  • 批准号:
    31972890
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DNA碱基损伤修复酶OGG1调控NF-κB磷酸化修饰的作用及机制研究
  • 批准号:
    31900557
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
动态m6A修饰调控自噬与抗病毒免疫交互反应的分子机理
  • 批准号:
    31970700
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
具核梭杆菌影响m6A修饰而调控cGAS免疫通路参与结直肠癌发生发展
  • 批准号:
    31970718
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
小桐子种子油含量关键靶基因的克隆与调控研究
  • 批准号:
    30871548
  • 批准年份:
    2008
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
一个籼稻Dicer-like蛋白基因的克隆、表达及功能分析
  • 批准号:
    30860155
  • 批准年份:
    2008
  • 资助金额:
    24.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10156474
  • 财政年份:
    2021
  • 资助金额:
    $ 100.3万
  • 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10410369
  • 财政年份:
    2021
  • 资助金额:
    $ 100.3万
  • 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
  • 批准号:
    10550159
  • 财政年份:
    2021
  • 资助金额:
    $ 100.3万
  • 项目类别:
Identification of fetal alcohol-affected children: Alterations in imprinted gene expression and methylation as biomarkers of neurobehavioral and growth impairment.
胎儿酒精影响儿童的鉴定:印记基因表达和甲基化的改变作为神经行为和生长障碍的生物标志物。
  • 批准号:
    10443791
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
Identification of fetal alcohol-affected children: Alterations in imprinted gene expression and methylation as biomarkers of neurobehavioral and growth impairment.
胎儿酒精影响儿童的鉴定:印记基因表达和甲基化的改变作为神经行为和生长障碍的生物标志物。
  • 批准号:
    10212186
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
Identification of fetal alcohol-affected children: Alterations in imprinted gene expression and methylation as biomarkers of neurobehavioral and growth impairment.
胎儿酒精影响儿童的鉴定:印记基因表达和甲基化的改变作为神经行为和生长障碍的生物标志物。
  • 批准号:
    10295640
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
Identification of fetal alcohol-affected children: Alterations in imprinted gene expression and methylation as biomarkers of neurobehavioral and growth impairment.
胎儿酒精影响儿童的鉴定:印记基因表达和甲基化的改变作为神经行为和生长障碍的生物标志物。
  • 批准号:
    9913250
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
Imprinted snoRNA loci and circadian entrainment
印记 snoRNA 位点和昼夜节律夹带
  • 批准号:
    10535437
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
Improvement of somatic cell nuclear transfer technology by regulation of histone methylation-dependent imprinted gene expression
通过调节组蛋白甲基化依赖性印记基因表达改进体细胞核移植技术
  • 批准号:
    19K16017
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Imprinted snoRNA loci and circadian entrainment
印记 snoRNA 位点和昼夜节律夹带
  • 批准号:
    10319981
  • 财政年份:
    2019
  • 资助金额:
    $ 100.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了